Back

New generation stents for primary percutaneous coronary intervention in patients with acute myocardial infarction: evidence from an individual patient data network meta-analysis of randomized clinical

2 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Acute Coronary Syndromes Revascularisation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Ply Chichareon

Prince of Songkla University, Hat Yai (Thailand)

6 More presentations in this session

Presentation thumbnail
Doctor Y. Kanaji (Tsuchiura, JP)
Abstract
Presentation thumbnail
Associate Professor D. Besh (Lviv, UA)
Abstract Slides
Presentation thumbnail
Doctor K. Tanaka (Osaka, JP)
Abstract
Presentation thumbnail
Ms E. Hartman (Rotterdam, NL)
Abstract
Presentation thumbnail
Doctor K. Setoyama (Kitakyushu, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Acute Coronary Syndromes

The Event

Event poster

ESC Congress 2019

2 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Intracoronary thrombolysis facilitated primary percutaneous coronary intervention in ST-segment elevation myocardial infarction patients: an updated meta-analysis of randomized controlled trials
27 August 2022
thumbnail
Congress Presentation
Comparison of two iterations of the zotarolimus-eluting stents: an analysis of all-comer patients from two consecutive randomised clinical trials
28 August 2020
thumbnail
Congress Presentation
Comparative effectiveness of pharmacologic agents for heart failure prevention in post-myocardial infarction patients: A comprehensive Bayesian network meta-analysis
4 April 2025
thumbnail
Congress Presentation
Percutaneous coronary intervention with 2nd generation drug eluting stent versus coronary artery bypass grafting in patients with unprotected left main disease: clinical outcome from a referral center
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources